JPH01168660A - Yl-0710m compound and production thereof - Google Patents
Yl-0710m compound and production thereofInfo
- Publication number
- JPH01168660A JPH01168660A JP32764487A JP32764487A JPH01168660A JP H01168660 A JPH01168660 A JP H01168660A JP 32764487 A JP32764487 A JP 32764487A JP 32764487 A JP32764487 A JP 32764487A JP H01168660 A JPH01168660 A JP H01168660A
- Authority
- JP
- Japan
- Prior art keywords
- compound
- culture
- formula
- strain
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 53
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 241000187747 Streptomyces Species 0.000 claims abstract description 8
- 238000012258 culturing Methods 0.000 claims abstract description 5
- 241000894006 Bacteria Species 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 4
- 241000187180 Streptomyces sp. Species 0.000 claims description 2
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 abstract description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 abstract description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 abstract description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- 230000001472 cytotoxic effect Effects 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 4
- 238000000926 separation method Methods 0.000 abstract description 3
- 210000004881 tumor cell Anatomy 0.000 abstract description 3
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 abstract description 2
- 239000003242 anti bacterial agent Substances 0.000 abstract description 2
- 239000002246 antineoplastic agent Substances 0.000 abstract description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 abstract description 2
- 238000000746 purification Methods 0.000 abstract description 2
- 239000007787 solid Substances 0.000 abstract description 2
- 241000192125 Firmicutes Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 15
- 239000000284 extract Substances 0.000 description 10
- 229920001817 Agar Polymers 0.000 description 9
- 239000008272 agar Substances 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 238000001819 mass spectrum Methods 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 241000894007 species Species 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000012458 free base Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000012980 RPMI-1640 medium Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000010446 mirabilite Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- RSIJVJUOQBWMIM-UHFFFAOYSA-L sodium sulfate decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].[O-]S([O-])(=O)=O RSIJVJUOQBWMIM-UHFFFAOYSA-L 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- -1 D-fracdose Chemical compound 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- 241000218589 Streptomyces olivaceus Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000007613 bennett's agar Substances 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- QYDYPVFESGNLHU-UHFFFAOYSA-N elaidic acid methyl ester Natural products CCCCCCCCC=CCCCCCCCC(=O)OC QYDYPVFESGNLHU-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000010699 lard oil Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- QYDYPVFESGNLHU-KHPPLWFESA-N methyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC QYDYPVFESGNLHU-KHPPLWFESA-N 0.000 description 1
- 229940073769 methyl oleate Drugs 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000006877 oatmeal agar Substances 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は、抗菌作用および細胞障害作用を有する新規な
YL−0710M化合物およびその製造法に関する。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a novel YL-0710M compound having antibacterial and cytotoxic effects and a method for producing the same.
(発明が解決しようとする問題点、解決するための手段
)
本発明の化合物は、下記の平面化学構造式で示されるY
L−0710M化合物である。(Problems to be solved by the invention, means for solving them) The compound of the present invention has the following planar chemical structural formula:
This is the L-0710M compound.
また9本発明の製造法は、ストレプトミセス属に属する
YL−0710M化合物生産菌を培養し。Further, in the production method of the present invention, YL-0710M compound-producing bacteria belonging to the genus Streptomyces are cultured.
培養物からYL−0710M化合物を採取することから
なる上記YL −0710M化合物の製造法である。This is a method for producing the above YL-0710M compound, which comprises collecting the YL-0710M compound from a culture.
(発明の効果)
YL −0710M化合物は、各種細菌株にダラム陽性
菌に対し、抗菌作用を示すと共に、各種腫瘍細胞に対し
9強い細胞障害作用を有しているので抗菌剤、抗腫瘍剤
として有用である。(Effects of the Invention) The YL-0710M compound exhibits antibacterial activity against various bacterial strains and Durham-positive bacteria, and also has a strong cytotoxic effect against various tumor cells, so it can be used as an antibacterial agent and an antitumor agent. Useful.
(1)抗菌作用
各種細菌に対するYL −0710M化合物の最少発育
阻止濃度(MIC)を表1に示す。(1) Antibacterial effect Table 1 shows the minimum inhibitory concentration (MIC) of the YL-0710M compound against various bacteria.
(2)腫瘍細胞を用いる試験管内細胞障害作用試験方法
:
1 x 10’ cells/mtに調整したL121
0”、 P2S5”の各細胞液1 mlに、エタノール
で溶解した各濃度のYL −0710M化合物4μtを
加え。(2) In vitro cytotoxicity test method using tumor cells: L121 adjusted to 1 x 10' cells/mt
4 μt of YL-0710M compound at each concentration dissolved in ethanol was added to 1 ml of each cell suspension of 0'' and P2S5''.
37℃炭酸ガス培養器中で3日間培養した後。After culturing for 3 days in a carbon dioxide incubator at 37°C.
トリバンプルー染色法により生残細胞を計数した。細胞
障害活性は、薬剤無添加の細胞数を対照として各濃度で
の細胞増殖抑制率を算出し、グラフ上にプロットして求
めた。Surviving cells were counted by Trivan blue staining method. Cytotoxic activity was determined by calculating the cell proliferation inhibition rate at each concentration using the number of cells without the addition of the drug as a control, and plotting the results on a graph.
使用したmedium :
It RPMI −1640+ 10%新生子牛血清
mW RPMI −1640+ 5%牛脂児血清+5
μM2−ヒドロキシエチル ジスルーフイド表2
(製造法)
YL−0710M化合物は、ストレプトミセス属にに属
するYL−0710M化合物生産菌を培養し、培養物か
らYL−0710M化合物を採取することにより製造す
ることができる。Medium used: It RPMI-1640+ 10% newborn calf serum mW RPMI-1640+ 5% beef tallow serum +5
μM2-hydroxyethyl disulfide Table 2 (Production method) The YL-0710M compound can be produced by culturing a YL-0710M compound-producing bacterium belonging to the genus Streptomyces and collecting the YL-0710M compound from the culture. .
この製造法で使用するYL −0710M化合物生産菌
の一例としては9本発明者等が沖縄県南大東島より分離
したストレプトミセス ニス・ピー(Streptom
yces sp、)YL−0710M株(微工研菌寄第
9728号)を挙げることができる。この菌株の菌学的
性状を以下に記す。An example of YL-0710M compound-producing bacteria used in this production method is Streptomyces nisp.
yces sp,) YL-0710M strain (Feikoken Bibori No. 9728). The mycological properties of this strain are described below.
(1)形態
本菌株は各種合成及び有機培地において生育し、特にス
ターチ・無機塩寒天培地、イースト麦芽寒天培地、ペプ
トン・イースト・鉄寒天培地で良好である。気菌糸はス
ターチ・無機塩寒天培地、オートミール寒天培地でよく
着生し、その色調は灰白〜灰色である。光学顕微鏡観察
によれば、気菌糸は単純分枝で。(1) Morphology This strain grows on various synthetic and organic media, particularly starch/inorganic salt agar, yeast malt agar, and peptone/yeast/iron agar. Aerial mycelium grows well on starch/inorganic salt agar medium and oatmeal agar medium, and its color is grayish-white to gray. According to light microscopy, aerial hyphae are simply branched.
先端が開いたらせん状(0pen 5piral )を
示し。It shows a spiral shape with an open tip (0pen 5piral).
形状はセクションスピラレス(S)である。電子顕微鏡
での観察で、胞子は50個程度の連鎖を認め、胞子の大
きさは0.5〜0,7 X O,8〜1.0μmであり
、その表面構造はとげ状である。輪生枝、胞子嚢及び菌
核形成は認められない。The shape is section spirales (S). By observation with an electron microscope, a chain of about 50 spores was observed, the size of the spores was 0.5 to 0.7 x O, 8 to 1.0 μm, and the surface structure was thorn-like. Whorled branches, sporangia, and sclerotia formation are not observed.
(2)各種寒天培地上の性状
各種寒天培地上の性状は、以下に示すとおりである。特
に記載しないかぎり、28℃で21日間培養し、常法に
従って観察したものである。色調の記載については色の
標準(日本色彩研究所)によった。(2) Properties on various agar media Properties on various agar media are as shown below. Unless otherwise specified, the cells were cultured at 28° C. for 21 days and observed according to conventional methods. The description of color tone was based on the color standard (Japan Color Research Institute).
表3
(3)生理的性質
表4
(注)生育温度は各温度(5,10,15,20,25
,28,30,33゜37.40,45.50℃)で、
7〜21日までの観察結果。Table 3 (3) Physiological properties Table 4 (Note) The growth temperature is at each temperature (5, 10, 15, 20, 25
,28,30,33°37.40,45.50°C),
Observation results from days 7 to 21.
ミルクに対する作用は37℃で3〜21日までの観察結
果。それ以外は特に指摘のないかぎり28℃で2週間後
の観察結果を示す。The effect on milk was observed at 37°C for 3 to 21 days. Unless otherwise specified, the results are shown after 2 weeks at 28°C.
(4) 炭素源の資化性
(プリドハム・ゴドリープ寒天培地、28°C培養)表
5
(注)+;生育する 士;生育が疑わしい−;生育しな
い
(5) ジアミノピメリン酸(DAP)の分析LEC
HVALIERらの方法(LECHVALIEI:R,
MP、 et al; PP 277−238 in
DIETZ、 A et al ed、、 Actin
omyceteTaXOnOmy+ SIM 5pec
ial publication No、6+ 198
0 )に従い9本菌株の酸加水分解物の分析を行った結
果。(4) Assimilation of carbon sources (Pridham-Godliep agar medium, 28°C culture) Table 5 (Note) +; Growing; Growth questionable -; Not growing (5) Analysis of diaminopimelic acid (DAP) LEC
The method of HVALIER et al. (LECHVALIEI:R,
MP, et al; PP 277-238 in
DIETZ, A et al ed, Actin
omyceteTaXOnOmy+ SIM 5pec
ial publication No. 6+ 198
Results of analysis of acid hydrolysates of nine bacterial strains according to 0).
LL−ジアミノピメリン酸が検出された。LL-diaminopimelic acid was detected.
以上の性状を要約すると、 YL−0710M株は。To summarize the above properties, the YL-0710M strain is.
各種寒天培地上で形成される気菌糸が単純分枝で、その
形状はセクションスピラレス(S)であり、50個程度
の胞子の連鎖が観察される。色相は生育がうす黄茶〜黄
茶、気菌糸が灰白〜灰を呈し、可溶性色素、メラニン様
色素の生成は認められない。また菌体の酸加水分解物の
分析よりLL−ジアミノピメリン酸が検出された。Aerial hyphae formed on various agar media are simply branched, the shape is section spirales (S), and chains of about 50 spores are observed. As for the hue, the growth is pale yellow-brown to yellow-brown, the aerial mycelia are gray-white to gray, and no production of soluble pigments or melanin-like pigments is observed. Furthermore, LL-diaminopimelic acid was detected by analysis of the acid hydrolyzed product of the bacterial cells.
上記諸性質より2本菌株はストレプトミセス(Stre
ptomyces )属に属する菌株と考えられ9本菌
株に類似する既知菌種を、[バーシーズ・マニュアル・
オプ・デタミネディプ・バクテリオロジー(Berge
y’s Manual of Detaminativ
e Bacteriology )第8版、 197
4年」、[インターナショナル・ジャーナル・オブ・シ
ステマティック・バクテリオロジー(Internat
ional Journal of Systemat
ic Bacteriology )第18巻、2号、
69−189頁、4号、 279−392頁(1968
)、第19巻、4号、 391−512頁(1969
)を第22巻、4号、 265−394頁(1972
) Jより検索した。その結果5本菌株に類似な菌とし
ては、ストレプトミセス オリバセウス(S、 oli
vaceus )とストレフトミセス シオヤネンシス
(S、 5ioyanensis )があげられる。ど
ちらの菌も気菌糸の形状、コロニーの色調、胞子の表面
構造9色素生成の有無などの性状においては本菌株と類
似しているが、炭素源の資化性(表6)及び各種培地上
の気菌糸の色調(表7)においてわずかに異っており9
本菌株と一致しない。以上の結果より本菌株をストレプ
トミセス属に属する新種であると判断し、ストレプトミ
セス ニス・ピー(Strepto−myces sp
、) YL −0710M株と命名した。本菌株は。Based on the above properties, the two strains are Streptomyces (Streptomyces).
Known bacterial strains similar to the nine strains, which are considered to belong to the genus Ptomyces), were
Op Detaminedip Bacteriology (Berge
y's Manual of Determinative
e Bacteriology) 8th edition, 197
International Journal of Systematic Bacteriology (International Journal of Systematic Bacteriology)
ional Journal of Systemat
ic Bacteriology) Volume 18, No. 2,
pp. 69-189, No. 4, pp. 279-392 (1968
), Volume 19, No. 4, pp. 391-512 (1969
) Vol. 22, No. 4, pp. 265-394 (1972
) Searched from J. As a result, Streptomyces olivaceus (S, oli
vaceus) and Streftomyces ioyanensis (S, 5ioyanensis). Both strains are similar to this strain in terms of properties such as the shape of aerial mycelia, color tone of colonies, and the presence or absence of pigment production on the surface structure of spores, but they are similar to this strain in terms of their ability to assimilate carbon sources (Table 6) and on various media. The color tone of the aerial mycelium (Table 7) differs slightly between 9 and 9.
It does not match this strain. Based on the above results, this strain was determined to be a new species belonging to the genus Streptomyces, and Strepto-myces sp.
) YL-0710M strain. This strain is.
工業技術院微生物工業技術研究所に微工研菌寄第972
8号として寄託されている。Microbiology Research Institute No. 972 at the Institute of Microbial Technology, Agency of Industrial Science and Technology
It has been deposited as No. 8.
表6 YL−0710Mと類似菌種との比較(炭素源
の資化性)表7 YL−0710Mと類似菌種との比
較(気菌糸の色調)本発明に用いられる菌株は、他の放
線菌にも見られるごとく1人工的にまた自然に変異をお
こしやすいが9本発明のい5 YL−0710M株は天
然から分離された放線菌、あるいはこれを紫外線、X線
、化学薬剤などで人工的に変異させた菌株及びそれらの
自然変異株をも包含するものである。Table 6 Comparison of YL-0710M with similar bacterial species (carbon source assimilation ability) Table 7 Comparison of YL-0710M with similar bacterial species (color tone of aerial hyphae) The bacterial strains used in the present invention are other actinomycetes As seen in 1, it is easy to cause mutations either artificially or naturally. It also includes bacterial strains that have been mutated and natural mutant strains thereof.
本発明の新菌種に属する微生物は天然の土壌より分離し
て取得したものであるが、前記微生物工業技術研究所に
寄託した菌株の凍結乾燥品を復元することによって容易
に取得することができる。本発明において、スプレブト
ミセス属に属するYL−0710M化合物生産菌の培養
は一般微生物の培養方法に準じておこなわれるが通常は
液体培地による深部培養法が有利である。培養に用いら
れる培地としては、該生産菌が利用する栄養源を含有す
る培地であればよい。すなわち合成培地、半合成培地あ
るいは天然培地が用いられ、培地の組成は、たとえば炭
素源としてはD−キシロース、グルコース、D−フラク
ドース、L−ラムノース、マンニトール、グリセリン、
デキストリン、澱粉、植物油などが。The microorganisms belonging to the new bacterial species of the present invention were obtained by isolation from natural soil, but they can be easily obtained by restoring the freeze-dried product of the strain deposited with the Microbial Technology Research Institute. . In the present invention, the YL-0710M compound-producing bacteria belonging to the genus Sprebutomyces is cultured according to the culture method of general microorganisms, but the deep culture method using a liquid medium is usually advantageous. The medium used for culturing may be any medium as long as it contains a nutrient source used by the producing bacteria. That is, a synthetic medium, a semi-synthetic medium or a natural medium is used, and the composition of the medium is, for example, carbon sources such as D-xylose, glucose, D-fracdose, L-rhamnose, mannitol, glycerin,
Dextrin, starch, vegetable oil, etc.
窒素源としては肉エキス、ペプトン、グルテンミール、
綿実粕、大豆粉、落花生粉、魚粉、コ′ −ンスチープ
リカー、乾燥酵母、酵母エキス。Nitrogen sources include meat extract, peptone, gluten meal,
Cottonseed meal, soybean flour, peanut flour, fishmeal, cornsteep liquor, dried yeast, yeast extract.
硫酸アンモニウム、硝酸アンモニウム、尿素その池の有
機または無機の窒素源が用いられる。Ammonium sulfate, ammonium nitrate, urea and other organic or inorganic nitrogen sources are used.
また金属塩としてNa、 K、 Mg、 Ca、 Zn
、 Feなどの硫酸塩、硝酸塩、塩化物、炭酸塩、燐酸
塩などが必要に応じて添加される。さらに必要に応じて
。Also, as metal salts, Na, K, Mg, Ca, Zn
, Fe and other sulfates, nitrates, chlorides, carbonates, phosphates, etc. are added as necessary. More if necessary.
メチオニン、システィン、シスチン、オレイン酸メチル
、ラード油、シリコン油、界面活性剤などの抗生物質生
成促進物質又は消泡剤が適宜使用される。Antibiotic production accelerators or antifoaming agents such as methionine, cysteine, cystine, methyl oleate, lard oil, silicone oil, and surfactants are used as appropriate.
培養条件としては好気的条件下に培養するのが一般的に
有利で、培養温度は約18〜35℃の範囲が望ましく、
好ましくは約30℃附近が用いられ、培地のpHは約5
〜10.好ましくは約6〜8の範囲に保持すると好結果
が得られる。培養期間は培地の組成、温度などによって
変動するが、一般に1〜5日程度でよく、培養終了時に
目的物質が選択的に蓄積される。As for the culture conditions, it is generally advantageous to culture under aerobic conditions, and the culture temperature is preferably in the range of about 18 to 35°C.
Preferably, the temperature is around 30°C, and the pH of the medium is around 5.
~10. Good results are obtained by keeping it preferably in the range of about 6-8. The culture period varies depending on the composition of the medium, temperature, etc., but is generally about 1 to 5 days, and the target substance is selectively accumulated at the end of the culture.
培養物から目的とするYL−0710M化合物を採取す
るには微生物の生産する代謝物の培養物から通常用いら
れる抽出1分離、精製の手段が適宜利用される。培養物
中のYL −0710M化合物は培養物そのままか、又
は遠心分離あるいは培養物にr過動剤を加えて濾過して
得ら、れた培養液に酢酸エチル等の水と混和しない有機
溶媒を加えて抽出する。又培養液を適宜の担体に接触さ
せP液中の目的有効成分を吸着させ、ついで適当な溶媒
で溶出する事により目的のYL −0710M化合物を
抽出する事が出来る。さらに詳しく述べるならば9例え
ばダイヤイオンHP −20またはCHP −20Pと
ゆうような多孔性吸着樹脂。In order to collect the target YL-0710M compound from the culture, extraction, separation, and purification means commonly used from the culture of metabolites produced by microorganisms are appropriately used. The YL-0710M compound in the culture can be obtained from the culture as it is, or by centrifugation or by adding a translucent agent to the culture and filtration, and adding a water-immiscible organic solvent such as ethyl acetate to the culture solution. Add and extract. Further, the desired YL-0710M compound can be extracted by bringing the culture solution into contact with a suitable carrier to adsorb the desired active ingredient in the P solution, and then eluting with a suitable solvent. More specifically, 9 porous adsorption resins such as Diaion HP-20 or CHP-20P.
もしくは例えばダウエクス50.アンバーライトIRC
50というようなイオン交換樹脂に接触させてYL−0
710M化合物を吸着させる。ついで該吸着樹脂の場合
にはメタノール、エタノール。Or, for example, DOWEX 50. Amber Light IRC
YL-0 by contacting with an ion exchange resin such as 50
Adsorb the 710M compound. Next, in the case of the adsorption resin, methanol and ethanol.
アセトン、アセトニトリル等の有機溶媒と水の混合溶媒
で、該イオン交換樹脂の場合には塩酸。A mixed solvent of water and an organic solvent such as acetone or acetonitrile, and in the case of the ion exchange resin, hydrochloric acid.
硫酸等の水溶液で溶出させる事によりYL−0710M
化合物含有画分を得る事ができる。YL-0710M by elution with an aqueous solution such as sulfuric acid.
Compound-containing fractions can be obtained.
酢酸エチル、酢酸ブチル等の有機溶媒で抽出する場合に
は培養r液にこれらの有機溶媒を加え、撹拌して抽出し
た後、得られた抽出液を酸性水で抽出し、ついで該酸性
抽出液を中和した後に、該有機溶媒で再び抽出するとい
う操作を繰り返す事により、 YL−0710M化合物
のより比率の高い両分を得る事ができる。つぎに上記の
各操作法を用いて得られたYL −0710M化合物含
有画分は常用の吸着処理2例えば活性炭。When extracting with an organic solvent such as ethyl acetate or butyl acetate, add these organic solvents to the culture liquid, stir and extract, and then extract the obtained extract with acidic water. By repeating the operation of neutralizing the compound and then extracting it again with the organic solvent, it is possible to obtain both components of the YL-0710M compound in higher proportions. Next, the YL-0710M compound-containing fraction obtained using each of the above-mentioned operating methods is subjected to a conventional adsorption treatment 2, such as activated carbon.
アルミナ、シリカゲル、セルロース等を担体に用いたカ
ラムクロマトグラフィー、薄層クロマトグラフィー等の
ような常法により分離する事ができる。このように培養
物中に生産されたYL−0710M化合物は遊離塩基の
形、すなわちYL−0710M化合物それ自体として分
離する事ができる。又このYL−0710M化合物遊離
塩基は酸、すなわち例え5ば塩酸、硫酸、燐酸等の無機
酸、又は例えば蟻酸、酢酸、クエン酸、酒石酸、p−ト
ルエンスルホン酸等の有機酸と常法により反応させると
それぞれの酸に対応する塩類にも変化させうる。Separation can be performed by conventional methods such as column chromatography, thin layer chromatography, etc. using alumina, silica gel, cellulose, etc. as a carrier. The YL-0710M compound thus produced in the culture can be separated as the free base form, ie, the YL-0710M compound itself. The free base of the YL-0710M compound can also be reacted with an acid, such as an inorganic acid such as hydrochloric acid, sulfuric acid, or phosphoric acid, or an organic acid such as formic acid, acetic acid, citric acid, tartaric acid, or p-toluenesulfonic acid, by a conventional method. It can also be converted into salts corresponding to each acid.
(実施例) つぎに実施例を挙げて9本発明をさらに説明する。(Example) Next, the present invention will be further explained with reference to Examples.
実施例
ポテトスターチ3.0%、小麦胚芽1.0%、コプラミ
ール1.0%、フェザ−ミール0.2%、炭酸カルシュ
ラム0.5%を含む培地(pH7,0)を作製し、これ
を500mZ三角フラスコに各60m1スつ分注し、1
20℃で20分間滅菌したものに、ベネット寒天培地上
に良く生育させたスプレブトミセス ニス・ビーYL
−0710M株の菌糸をかき取って接種し、28℃で4
8時間振盪培養を行ない種培養液とする。つぎにデキス
トリン2.0%、コーンスチープリ力−0.5%、ポリ
ペプトン0.5%、酵母エキス0.5%。Example A medium (pH 7.0) containing 3.0% potato starch, 1.0% wheat germ, 1.0% copra meal, 0.2% feather meal, and 0.5% calcium carbonate was prepared. Dispense one 60ml volume into each 500mZ Erlenmeyer flask, and
Sprebtomyces Nis bee YL grown well on Bennett agar medium after sterilization at 20°C for 20 minutes
-0710M strain was scraped and inoculated, and incubated at 28℃ for 4 hours.
Culture with shaking for 8 hours and use as a seed culture solution. Next, 2.0% dextrin, 0.5% corn steeple, 0.5% polypeptone, and 0.5% yeast extract.
肉エキス0.3%、プレインハートインフユージョン0
.52%、炭酸カルシーウム0.5%を含む培地(pH
8,0)を106作製し、これを500m1三角フラス
コに各60m1ずつ分注し、120℃で20分間滅菌し
たものに、上記種培養液を3.0%の割合で植菌し。Meat extract 0.3%, plain heart infusion 0
.. 52%, calcium carbonate 0.5% (pH
8,0) was prepared, 60 ml of each was dispensed into 500 ml Erlenmeyer flasks, sterilized at 120° C. for 20 minutes, and the above seed culture solution was inoculated at a rate of 3.0%.
28℃で96時間培養した。The cells were cultured at 28°C for 96 hours.
このようにして得られた培養液にラジオライト≠600
(昭和化学工業社製)を加えて撹拌した後に沢過し1.
8tの培養液を得た。このF液をpH8,0とし、酢酸
エチルを4tずつ2回に分けて加え撹拌し、抽出した。Radiolight≠600 was added to the culture solution thus obtained.
(manufactured by Showa Kagaku Kogyo Co., Ltd.) and stirred, then filtered 1.
8 tons of culture solution was obtained. This F solution was adjusted to pH 8.0, and ethyl acetate was added in two portions of 4 tons each, followed by stirring and extraction.
この抽出液を100ntまで減圧濃縮し、 50℃乙
の水を加え、1規定塩酸で水層をpH2,5に調整し、
よく撹拌して目的物を抽出した。This extract was concentrated under reduced pressure to 100 nt, water at 50°C was added, and the aqueous layer was adjusted to pH 2.5 with 1N hydrochloric acid.
The target product was extracted by stirring well.
この操作を4回繰り返して合計200mZの酸性抽出液
を得た。この酸性抽出液に5On+Zの酢酸エチルを加
え、1規定の苛性ソーダで水層なpH8,0に調整し、
よく撹拌して再抽出した。この操作を4回繰り返して合
計200m1のYL −0710M化合物の酢酸エチル
抽出液を得た。この抽出液に芒硝を加えてよく脱水した
後に芒硝をf過して除去し、F液を減圧濃縮乾固し、2
38■の粗YL−0710M化合物を得た。このように
して得られた粗YL −0710M化合物を外径1.5
cm、長さ100cmのシリカゲル(ワコーゲルC−3
00・和光純薬工業株式会社製)のカラムに付し、酢酸
エチルで展開し、その溶出液を各10gずつフラクショ
ンコレクターで分画した。目的のYL −0710M化
合物はフラクションナンバー6から21の間に溶出され
た。その活性はバチルスズブチリス ATCC6633
株の寒天プレートで検定して確認し、又物質の確認には
シリカゲルプレート(キーゼルゲル60F2り4,20
0mX20cm・メルク社製)を用い、クロロホルム:
メタノール(90:10)の溶媒で展開する薄層クロマ
トグラフィーで目的のYL −0710M化合物(Rt
= 0.47 )をUVランプ(254nm)で確認
した。This operation was repeated four times to obtain an acidic extract with a total concentration of 200 mZ. 5On+Z ethyl acetate was added to this acidic extract, and the pH of the aqueous layer was adjusted to 8.0 with 1N caustic soda.
The mixture was thoroughly stirred and re-extracted. This operation was repeated four times to obtain a total of 200 ml of an ethyl acetate extract of the YL-0710M compound. After adding Glauber's salt to this extract and thoroughly dehydrating, the Glauber's salt was removed by filtration, and the F solution was concentrated to dryness under reduced pressure.
38 ml of crude YL-0710M compound was obtained. The crude YL-0710M compound thus obtained was
cm, length 100cm of silica gel (Wakogel C-3
00 (manufactured by Wako Pure Chemical Industries, Ltd.) and developed with ethyl acetate, and the eluate was fractionated in 10 g portions using a fraction collector. The target YL-0710M compound was eluted between fraction numbers 6 and 21. Its activity is Bacillus subtilis ATCC6633
Confirm by assaying on an agar plate of the strain, and use a silica gel plate (Kieselgel 60F2 4,20
Chloroform:
The target YL-0710M compound (Rt
= 0.47) was confirmed using a UV lamp (254 nm).
この溶出画分で割合純度の高いフラクション(フラクシ
ョンナンバー6から14)を集め、減圧濃縮乾固して1
4.OfDgの粗YL−0710M化合物を得た。Fractions with high relative purity (fraction numbers 6 to 14) were collected from this elution fraction and concentrated to dryness under reduced pressure.
4. Crude YL-0710M compound of OfDg was obtained.
この粗YL−0710M化合物をさらに純粋にするため
にシリカゲルプレート(キーゼルゲル60F254゜2
0 cm X 20 am・メルク社製)の3枚に下か
ら2cm0所に帯状にチャージし、クロロホルム:メタ
ノール(90:10)で15cm展開し、風乾した後に
UVランプ(254nm)でYL −0710M化合物
(Rf = 0.47 )を確認し、この部分をかき取
り、こレヲクロロホルム:メタノール(90: 10)
ノ溶媒を用いて溶出し、その溶出液を減圧濃縮乾固する
事により純粋なYL−0710M化合物を6.0mg得
た。In order to further purify this crude YL-0710M compound, a silica gel plate (Kieselgel 60F254°2
0 cm x 20 am (manufactured by Merck & Co.) was charged in a strip at 2 cm from the bottom, developed for 15 cm with chloroform:methanol (90:10), air-dried, and then exposed to the YL-0710M compound using a UV lamp (254 nm). (Rf = 0.47), scrape off this part, and add chloroform:methanol (90:10).
The eluate was concentrated to dryness under reduced pressure to obtain 6.0 mg of pure YL-0710M compound.
上記抽出9分離、精製されたYL−0710M化合物遊
離塩基は、下記の物理化学的性質を有する。The free base of YL-0710M compound separated and purified in the above extraction 9 has the following physicochemical properties.
(1) 色および形状;淡黄色無定形の固体(2)酸
性、中性、塩基性の区別;塩基性(3)溶解性;メタノ
ール、エタノール、アセトン。(1) Color and shape; pale yellow amorphous solid; (2) Distinction between acidic, neutral, and basic; basic; (3) Solubility; methanol, ethanol, acetone.
酢酸エチル、酢酸フチル、ベンゼン、トルエン。Ethyl acetate, phtyl acetate, benzene, toluene.
クロロホルムには溶けるが水には溶けに<<。It dissolves in chloroform but not in water.
ヘキサンにはほとんど溶けない。Almost insoluble in hexane.
(4)紫外部吸収スペクトル; YL−0710M化合
物の紫外部吸収スペクトルは第1図に示すごとくである
。(4) Ultraviolet absorption spectrum; The ultraviolet absorption spectrum of the YL-0710M compound is as shown in FIG.
(5)分子量; 573(M+1)、 595[M十N
a〕(FAB−Mass)(6) 分子式; C29
H4ON4011 (高分解能マススペクトル)(7)
ctマススペクトル; YL−0710M化合物の
CIマススペクトルは第2図に示すごとくである。(5) Molecular weight; 573 (M+1), 595 [M1N
a] (FAB-Mass) (6) Molecular formula; C29
H4ON4011 (high resolution mass spectrum) (7)
CT mass spectrum: The CI mass spectrum of the YL-0710M compound is as shown in FIG.
(8)”H−NMRスペクトル; YL−0710M化
合物のI−H−NMRスペクトルは第3図に示すごとく
である。(8) "H-NMR spectrum; The I-H-NMR spectrum of the YL-0710M compound is as shown in FIG. 3.
(9) ”−C−N M Rスペクトル; YL−0
710M化合物の13−C−N M Rスペクトルは第
4図に示すごとくである。(9) “-C-N MR spectrum; YL-0
The 13-C-NMR spectrum of the 710M compound is as shown in FIG.
上記の物理化学的性質からYL −0710M化合物の
構造式は下記のように決定される。From the above physicochemical properties, the structural formula of the YL-0710M compound is determined as follows.
【図面の簡単な説明】
第1図は、YL−0710M化合物の紫外部吸収スペク
トルを示す。
第2図は、YL−0710M化合物のCIマススペクト
ルを示す。
第3図は、YL−0710M化合物のIH−核磁気共鳴
スペクトルを示す。
第4図&t、 YL−0710M化合物ノl3c−核磁
気共鳴スベクトルを示す。
長井省=
第1図
・;皮長(nm )BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 shows the ultraviolet absorption spectrum of the YL-0710M compound. FIG. 2 shows the CI mass spectrum of the YL-0710M compound. FIG. 3 shows the IH-nuclear magnetic resonance spectrum of the YL-0710M compound. FIG. 4 &t shows the nuclear magnetic resonance spectrum of YL-0710M compound. Nagai = Figure 1: Skin length (nm)
Claims (3)
物。 ▲数式、化学式、表等があります▼(1) YL-0710M compound represented by the following planar structural formula. ▲Contains mathematical formulas, chemical formulas, tables, etc.▼
合物生産菌を培養し、培養物からYL−0710M化合
物を採取することを特徴とする下記平面構造式で示され
るYL−0710M化合物の製造法。 ▲数式、化学式、表等があります▼(2) A method for producing a YL-0710M compound represented by the following planar structural formula, which comprises culturing a YL-0710M compound-producing bacterium belonging to the genus Streptomyces and collecting the YL-0710M compound from the culture. ▲Contains mathematical formulas, chemical formulas, tables, etc.▼
ス エス・ピー(Storeptomyces sp.
)YL−0710M(微工研菌寄第9728号)である
特許請求の範囲第(2)項記載の製造法。(3) The YL-0710M compound producing bacterium is Streptomyces sp.
) YL-0710M (Feikoken Bibori No. 9728), the manufacturing method according to claim (2).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32764487A JPH01168660A (en) | 1987-12-24 | 1987-12-24 | Yl-0710m compound and production thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32764487A JPH01168660A (en) | 1987-12-24 | 1987-12-24 | Yl-0710m compound and production thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01168660A true JPH01168660A (en) | 1989-07-04 |
Family
ID=18201356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP32764487A Pending JPH01168660A (en) | 1987-12-24 | 1987-12-24 | Yl-0710m compound and production thereof |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01168660A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130231377A1 (en) * | 2010-08-02 | 2013-09-05 | Oregon State University | Pactamycin analogs and methods of use |
US8957251B2 (en) | 2007-04-19 | 2015-02-17 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Pactamycin analogs and methods of making thereof |
-
1987
- 1987-12-24 JP JP32764487A patent/JPH01168660A/en active Pending
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8957251B2 (en) | 2007-04-19 | 2015-02-17 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Pactamycin analogs and methods of making thereof |
US9452976B2 (en) | 2007-04-19 | 2016-09-27 | Oregon State University | Pactamycin analogs and methods of making thereof |
US20130231377A1 (en) * | 2010-08-02 | 2013-09-05 | Oregon State University | Pactamycin analogs and methods of use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6016236B2 (en) | Production method of antibiotic C-15003 P-3 | |
KR100230961B1 (en) | Novel amimooligosaccharide derivative and process for preparing the same | |
EP0387712B1 (en) | WS 7622 A,B,C and D substances, derivatives thereof, processes for preparation thereof and use thereof | |
JPH01168660A (en) | Yl-0710m compound and production thereof | |
US4550021A (en) | Antitumor antibiotic 81-484 and process for its production | |
JPH03157372A (en) | Yl-01869p substance and production thereof | |
JP5036554B2 (en) | Novel stemphone compounds and process for producing the same | |
JPH0625095B2 (en) | Antibiotic SF-2415 substance and its production method | |
JPS6348284A (en) | Novel antibiotic yp-02908l-a and production thereof | |
KR810000686B1 (en) | Process for the preparation of piperidine derivative | |
JPS63170392A (en) | Scm-127 substance and preparation thereof | |
JPS59170092A (en) | Novel antibiotic, ss8201d and its preparation | |
JP2786219B2 (en) | Y-09194L-B substance and method for producing the substance | |
JP2795489B2 (en) | New substance DC115A compound | |
JPS62175493A (en) | Novel antibiotic yp-02908l-a and production thereof | |
JPH0398591A (en) | New antibiotic substance having antitumor activity and production thereof | |
JPWO2006095444A1 (en) | Stemphones and methods for their production | |
JPS62186787A (en) | Novel microorganism | |
JPH0259596A (en) | Novel substance, utilization and production thereof | |
JPS63280073A (en) | Novel antibiotic yp-02978l-c and production thereof | |
JPS6344581A (en) | Substance yl-0358m-a and production thereof | |
JPS6230735A (en) | Novel antibiotic substance sf-2418 and production thereof | |
JPS6037991A (en) | Antibiotic substance ss8228c and its preparation | |
JPS62275687A (en) | Yp-02259l-a and c substance and production thereof | |
JPH08208644A (en) | New antibiotic substance cremimycin, its production and use |